文章摘要
柯珂 余云熹 余竹金 张斌 王晓琴.弥漫性大B 细胞淋巴瘤hs-CRP和VEGF的表达及与化疗耐药的相关性[J].,2015,15(26):5150-5152
弥漫性大B 细胞淋巴瘤hs-CRP和VEGF的表达及与化疗耐药的相关性
Relationship between Expression of hs-CRP and VEGF in Diffuse LargeB-cell Lymphoma and Chemotherapy Resistance
  
DOI:
中文关键词: 弥漫性大B 细胞淋巴瘤  超敏C-反应蛋白  血管内皮生长因子
英文关键词: Diffuse large B-cell lymphoma  hs-CRP  VEGF
基金项目:
作者单位
柯珂 余云熹 余竹金 张斌 王晓琴 湖北省黄石市中心医院普爱院区头颈食管淋巴瘤肿瘤内科湖北省黄石市中医医院团城山院区内六科湖北省大冶市妇幼保健院妇产科湖北省大冶市妇幼保健院 
摘要点击次数: 730
全文下载次数: 0
中文摘要:
      目的:研究弥漫性大B 细胞淋巴瘤超敏C- 反应蛋白(hs-CRP)和血管内皮生长因子(VEGF)的表达及与化疗耐药的相关性。 方法:选取2013 年11 月到2014 年11 月我院收治的化疗耐药弥漫性大B 细胞淋巴瘤25 例(A 组),化疗敏感弥漫性大B 细胞淋 巴瘤25 例(B组),另选取同期健康者25 例(C 组)。应用免疫荧光法检测三组入选者的hs-CRP,及酶联免疫吸附法试验(ELISA) 法检测VEGF。结果:化疗前A 组hs-CRP、VEGF水平显著高于B 组和C 组,B 组高于C 组,比较差异具有统计学意义(P< 0.05); 化疗缓解后A组和B组hs-CRP、VEGF水平与化疗前比显著降低,差异有统计学意义(P<0.05),但两组间比较差异无统计学意 义(P>0.05);A组复发耐药后hs-CRP、VEGF 水平与缓解后比显著升高,差异具有统计学意义(P<0.05)。结论:弥漫性大B细胞 淋巴瘤血清中hs-CRP、VEGF水平改变与病情变化有关,可能与化疗耐药有关。
英文摘要:
      Objective:To study the relationship between expression levels of hs-CRP and vas- cular endothelial growth factor (VEGF) in diffuse large B-cell lymphoma and chemotherapy resistance.Methods:A total of 25 cases of diffuse large B-cell lymphoma with chemotherapy resistance were selected as group A; 25 cases of diffuse large B-cell lymphoma with chemotherapy sensitivity were selected as group B; 25 healthy people in the same period, who were all admitted to Huangshi Central Hospital from November 2013 to November 2014 were selected as group C. The hs-CRP levels of three groups were detected by immunofluorescence, and the levels of VEGF, were detected by enzyme-linked immunosorbent assay test (ELISA).Results:The levels of hs-CRP and VEGF in group A were significantly higher than those in group B and group C, those in group B were higher than those in group C before chemotherapy, the differences were statistically significant (P<0.05). Compared to before chemotherapy, the levels of hs-CRP and VEGF in group A and group B significantly decreased after chemotherapy remission, the differences were statistically significant (P<0.05), but the difference between the two groups was not statistically significant (P>0.05). Compared to after chemotherapy remission, the levels of hs-CRP and VEGF in group A significantly increased after recurrence of resistance, the differences were statistically significant (P<0.05).Conclusion:The change of hs-CRP and VEGF levels in diffuse large B-cell lymphoma is related to the patients' condition changes, which may be associated with chemotherapy resistance.
查看全文   查看/发表评论  下载PDF阅读器
关闭